Kurma Partners

Get funding

Kurma Partners is a management company specializing in the financing of innovation in healthcare and biotechnology.

Use: Go2Market;
Date closing: -
Amount: -
Industry focus: Health;
Total budget: 160M €
Entity type: Venture Capital
Vertical focus: Life Science, Biotech, Pharma
Website: https://www.kurmapartners.com/en

Status:
Open
Funding type: Equity investment;
Geographic focus: Europe;
Public/Private: Private
Stage focus: Seed; Series A;
Applicant target: Startup;

Add a Review Send question

Overview

Kurma Partners has built a strong network of partners with the best European academic research players, to transform their disruptive scientific discoveries into cutting-edge medicines or medical devices to diagnose and treat patients with severe diseases with high unmet medical need.

Their ambition is to work with leading European research centers to build the healthcare industry of tomorrow. Kurma Partners has raised a total of €534M across 6 funds, their latest being Growth opportunities fund, Tibi. This fund was announced on Mar 7, 2022 and raised a total of €160M.

Portfolio: AM Pharma, Meiogenix, BLiNK, Edifecs.

Last updated on 2023-04-25 13:01